Canesten Ultra

Quick links

Choose a section

Quick links to important sections

Advertisements

Canesten Ultra

Advertisements
Advertisements

Method of action: Antifungal Broad Spectrum

Treatment option: Hyperhidrosis

Advertisements

Overview of Canesten Ultra

Quick Facts

Property Description
Active ingredient Bifonazole (INN)
Form Dermatological Cream (Topical)
Pharmacological class Antifungal / Antimycotic
General purpose Counteracts the cause of superficial fungal skin infections
Origin Synthetic (Imidazole derivative)

What Type of Medicine is Canesten Ultra?

Canesten Ultra is a dermatological preparation intended for direct external use on the skin, supplied in the dosage form of a cream. Its essential identity is defined by its pharmacological classification as an antifungal (antimycotic) agent; specifically, it belongs to the azole group of medicines. As a single-component monotherapy designed for cutaneous application, Canesten Ultra is positioned as a targeted topical treatment.

This medicine is clinically recognized for its efficacy against a broad range of dermatophytes and yeasts. Bifonazole serves as a therapeutic option for surface infections. Its identity as a targeted antifungal clarifies that its function is to address the underlying cause of infection, not merely its symptoms.

Understanding the Key Ingredient: Bifonazole

The central working substance in Canesten Ultra is Bifonazole (INN), which is a synthetic substituted imidazole derivative. Bifonazole is the sole active component, formulated into a suitable dermatological cream base (vehicle). The formulation focuses on delivering the active substance efficiently to the affected layers of the skin.

Bifonazole's composition is distinguished by the unique structural features that grant it its dual mechanism of action. Bifonazole acts by interfering with ergosterol synthesis in fungal cell membranes. This feature provides the foundation for its therapeutic purpose.

What is the General Purpose of this Antifungal Cream?

The general therapeutic purpose of Canesten Ultra is to counteract the presence and proliferation of fungi that cause superficial skin infections, a typical use scenario. This is achieved through the Bifonazole's mechanism, which first inhibits the growth and spread of the fungi (fungistatic) and then actively leads to the destruction of the organisms (fungicidal) at therapeutic concentrations. This comprehensive action, which addresses the pathogen directly, is the fundamental benefit offered by the preparation.

Regulatory References

  1. Antifungal Ergosterol Synthesis Inhibitors - StatPearls - NCBI Bookshelf
Advertisements

What side effects are possible with Canesten Ultra?

Possible Side Effects and Safety Information

The official safety profile for Bifonazole cream (Canesten Ultra) is primarily defined by local dermatological reactions at the application site, which are classified by frequency in regulatory documents. Systemic adverse reactions are documented as rare, with attention paid to potential hypersensitivity and drug interactions.

Adverse Reaction Classification

Adverse effects are documented according to regulatory frequency conventions:

Frequency Category Associated Adverse Reactions
Very Common (1/10) Burning sensation/Burning skin.
Uncommon (1/1,000, < 1/100) Erythema, Eczema, Skin irritation, Pruritus (itching).
Not Known Systemic hypersensitivity reactions, Allergic dermatitis, Rash, Blister, Skin exfoliation, Administration site pain, Peripheral oedema.

These reactions primarily fall under the regulatory categories of Skin and Subcutaneous Tissue Disorders and General Disorders at the Administration Site. Local adverse effects are generally considered reversible upon discontinuation of the cream.

Population-Specific Safety Notes

The regulatory labeling includes specific safety considerations for vulnerable groups:

  • Pregnancy and Lactation: Use during the first trimester of pregnancy is generally avoided as a precautionary measure. During lactation, application to the chest area must be avoided.
  • Neonates and Infants: Use in infants and neonates should occur under medical supervision.
  • Patients on Oral Anticoagulants: Limited data suggests a potential for interaction with warfarin, which may lead to an increase in the International Normalized Ratio (INR), requiring monitoring during concomitant use.

Safety limitations also note that the excipients Cetostearyl alcohol and Benzyl alcohol may cause local skin reactions. Caution is advised for individuals with known cross-sensitivity to other imidazole antifungals.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope

Feature Official Regulatory Statement
Documented overdose presentations No risk of acute intoxication is anticipated following an overdose through dermal application; local skin reactions such as erythema or irritation are the potential manifestations of applying too much cream to the skin.
Physiological systems affected (as stated in label) Gastrointestinal symptoms (e.g., nausea, vomiting) are the primary concern only following accidental oral ingestion of the cream. Systemic toxicity is not documented for topical overuse due to negligible percutaneous absorption.
Dose-related or exposure-related factors (if applicable) The low systemic absorption of the active ingredient makes the risk of a systemic overdose unlikely after excessive topical use [SmPC].
When immediate medical help is required (label-derived phrasing only) Urgent medical assistance is required if the cream is inadvertently swallowed. Contact a Poisons Information Centre or seek immediate medical advice [Health Authority Label].

Overdose Classifications (High-Level)

Classification Official Regulatory Statement
Severity classification (as defined in official documents) Acute overdose from dermal use is generally classified as low risk.
Regulatory basis (EMA / FDA / etc.) Based on the Summary of Product Characteristics and government-authorized prescribing information.

Resulting Overdose Structure

Official Overdose Statements:

  • No specific antidote is known for Bifonazole overdose.
  • Treatment for overdose is symptomatic and supportive.
  • Procedural measures such as gastric lavage should only be considered following accidental oral ingestion and only if clinical symptoms of systemic exposure are present.

Connection to the overall overdose profile (2–4 sentences): The official overdose profile is defined by the negligible systemic absorption of the topical formulation, which regulatory documents state results in a low risk of acute intoxication from dermal overuse. Immediate medical attention is explicitly mandated by regulatory authorities only for cases of accidental oral ingestion, which is the only scenario where systemic exposure potentially requires supportive measures to manage symptoms, as no specific antidote is available.

Advertisements

Therapeutic Uses of Canesten Ultra

What Canesten Ultra Treats: Main Uses and Benefits

The cream is commonly used to help manage the presence of superficial fungal skin infections caused by dermatophytes and yeasts. The core therapeutic domain involves use in areas where short-term symptom management is appropriate, with clinical utility relevant for conditions where symptoms may intensify temporarily.

This includes treating common conditions like Athlete's foot (Tinea pedis), Ringworm (Tinea corporis), and Jock itch (Tinea cruris), as well as managing Yeast Infections and Pityriasis versicolor. The application is relevant for managing symptom clusters that may become intense or disruptive, and is applied across domains where additional symptomatic support is needed.

The treatment is used to address distressing manifestations, including the pronounced itching (pruritus), painful burning sensation, and visible damage such as excessive scaling, flaking, and redness (erythema). The primary therapeutic focus is relevant for easing acute symptomatic episodes and contributes to easing the overall symptom load. This action provides supportive relief when symptoms create noticeable physiological strain and supports general well-being during symptomatic phases.


Quick Fact: Relief for Acute Fungal Symptoms
Symptom Focus Itching, burning, scaling, and skin redness.
Therapeutic Scope Tinea infections (Athlete's foot, Ringworm) and Cutaneous Candidiasis.
Clinical Context Applied during phases when symptoms become more noticeable and disruptive.
Patient Benefit Contributes to easing the overall symptom load and supports improved comfort.
Advertisements

Eligibility and Restrictions for Use

Official Eligibility for Canesten Ultra (Bifonazole)

The use of Canesten Ultra is defined by specific eligibility rules outlined in official regulatory documents, based on absolute contraindications and conditional use requirements for certain populations.

Absolute Contraindications The medicine is strictly prohibited (contraindicated) for individuals with a known hypersensitivity or allergy to the active substance, Bifonazole, or any of the product’s excipients. It is also strictly prohibited for the treatment of infant nappy rash.

Age-Related Restrictions Canesten Ultra is approved for use in adults, adolescents, and older children. However, regulatory documents specify that use in neonates and infants (under two years of age) is restricted and should only be undertaken under medical supervision.

Conditional Use Populations

  • Pregnancy: Use is not normally recommended and is preferably avoided in the first trimester. It should only be used after a doctor has performed a benefit-risk evaluation.
  • Lactation: The product should not be used in nursing mothers; if treatment is necessary, a decision must be made to discontinue breastfeeding or discontinue the therapy. It must not be applied to the chest area.
  • Other Imidazoles: Caution is required for patients with a history of hypersensitivity reactions to other antifungal agents in the imidazole class.

No specific contraindications or mandatory dose adjustments are documented in the official labeling for patients with existing hepatic or renal impairment.

Advertisements

What should I know about interactions with other medicines?

Official Interaction Profile

The official regulatory profile for topical bifonazole is primarily defined by the minimal systemic absorption of the active substance through the skin, resulting in few officially documented interactions. All statements regarding interaction patterns are derived exclusively from authoritative government regulatory documents.

Drug-Drug Interactions

A potential pharmacokinetic interaction has been documented with Oral Anticoagulants, specifically medicines like Warfarin. Limited data suggest that co-administration of topical bifonazole may lead to an increase in the International Normalized Ratio (INR), which is an indicator of enhanced anticoagulant effect. Due to this potential outcome, if the cream is used in a patient taking an anticoagulant, the anticoagulant effect must be appropriately and closely monitored by a healthcare professional. This constraint is relevant when the cream is applied to a large skin surface area or to damaged skin. No medicinal products are formally classified as contraindicated combinations.

Product-Excipient Restrictions

An official restriction relates to non-medicine products. The excipients (inactive ingredients), such as cetostearyl alcohol, contained within the cream formulation may reduce the effectiveness and safety of Latex Products, including barrier contraceptives like condoms and diaphragms, when the cream is applied to the genital area.

Advertisements

Mechanism of Action

Dual Mechanism: Disruption of Fungal Cell Structure

The mechanism of action for the active ingredient, Bifonazole, involves a dual inhibition within the fungal organism's vital ergosterol biosynthesis pathway. The molecule acts as an inhibitor against two separate enzymes essential for ergosterol production: Lanosterol 14-alpha-demethylase and HMG-CoA Reductase. This sequential, dual inhibition decreases the rate of ergosterol production and causes the accumulation of toxic intermediate sterols. The resulting physiological effect is the complete destabilization of the fungal cell structure. This profound physiological disruption results in the inhibition of fungal cell proliferation (fungistatic effect) and the induction of fungal cell lysis (fungicidal effect).


️ Modulation of Local Skin Processes

Beyond its primary antifungal effect, Bifonazole engages mechanisms that modulate local physiological activity. The molecule intrinsically possesses an anti-inflammatory property by influencing the local signaling pathways, resulting in the modulation of the expression of specific pro-inflammatory mediators within the surrounding skin tissue. This secondary action results in the modulation of the local inflammatory response, which occurs concurrently with the primary antifungal mechanism.

Advertisements

Dosage and Administration Information

Canesten Ultra (Bifonazole 1% cream) is for cutaneous use only. The medicine is applied once daily, typically in the evening before retiring. A small quantity, approximately pea-sized, is sufficient to treat a surface area equivalent to the palm of the hand. This thin layer is gently rubbed into the affected skin region. Proper application involves washing and drying the skin area thoroughly immediately prior to use. The preparation is not intended for use with occlusive bandages or dressings.

Official Treatment Duration

Fungal Infection Standard Labeled Course
Athlete's Foot (Tinea pedis) 3 weeks
Ringworm (Tinea corporis) / Jock Itch (Tinea cruris) 2–3 weeks
Yeast Infections (Cutaneous candidiasis) 2–4 weeks

Treatment involves completing the full duration of the course, even if the infection appears to have cleared. For cases involving infants and children, use is intended to occur under the supervision of a medical professional. If an application is missed, it is applied as soon as it is remembered, though a double dose is not to be applied to compensate.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Chronic Fungal Infections

Studies explored the use of the active ingredient, bifonazole (the antifungal agent in Canesten Ultra), in the context of conditions involving severe fungal skin infections, such as tinea pedis (athlete’s foot) and cutaneous candidiasis. Clinical trials specifically evaluated the influence of bifonazole application on patient-reported quality of life measures.

Research examined the use of bifonazole in comparison to other established antifungal agents, such as clotrimazole. In one study of pityriasis versicolor, the investigation of bifonazole demonstrated comparable findings to clotrimazole concerning clinical and mycological endpoints at four weeks.

Research in Specific Populations

Elderly Patients and Renal Function

Research studies assessed the investigation of the drug in elderly patients, noting that some studies examined the effect of varying initial dosages. The research focused on pharmacokinetic differences and participant reporting in this demographic, as age-related changes in organ function can influence drug handling.

Studies included liver function monitoring in participants to assess safety margins. Research also evaluated the drug in populations with pre-existing kidney issues, though the clinical significance of any observed pharmacokinetic changes in topically applied bifonazole, a drug with low systemic absorption, remains a subject of ongoing investigation.

Comparative Research

Some studies included a research focus related to other azoles and allylamines. Comparisons primarily focused on how participants reported the study drug compared to effects across various pain states, rather than establishing superiority over established therapies. Limited evidence suggested that bifonazole may be a research focus related to NSAIDs in participants with reported gastrointestinal sensitivity.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Canesten Ultra (FAQ)


Q: Is Canesten Ultra the same thing as the regular Canesten cream?

A: The active ingredient in Canesten Ultra is bifonazole. The medication often known as 'regular Canesten' (for certain uses) typically contains a different active ingredient, such as clotrimazole. While both substances belong to the same antifungal medicine class, official documentation shows they have distinct chemical structures and use patterns.


Q: How quickly does Canesten Ultra start to work after I put it on?

A: Studies and official information indicate that the active ingredient, bifonazole, has an anti-inflammatory property that is described to occur at the same time as its primary antifungal action. However, regulatory documents do not specify a precise time frame for when symptom relief may begin. The official use protocol describes continuous application for the full treatment duration as being necessary to address the underlying infection.


Q: Does Canesten Ultra help with the itchiness right away?

A: The active substance in the cream possesses an anti-inflammatory property that may help modulate local signaling pathways in the skin. This effect is intended to work concurrently with the main antifungal action. The specific time until relief from symptoms like itching (pruritus) begins is not stated in the official product information.


Q: Can Canesten Ultra be used for all types of fungal infections?

A: According to official product information, the product is indicated for the treatment of superficial fungal skin infections caused by dermatophytes, yeasts, molds, and other fungi. Official indications describe the use of the active ingredient, bifonazole, for conditions like athlete's foot, ringworm, and cutaneous candidiasis, among others.


Q: Is Canesten Ultra meant only for athlete's foot?

A: No, official indications for use include more than just athlete's foot (tinea pedis). Regulatory documents confirm the product is also indicated for other fungal skin infections, including ringworm (tinea corporis), jock itch (tinea cruris), and cutaneous candidiasis (a type of yeast infection).


Q: Is it normal to feel a mild burning or stinging when first applying Canesten Ultra?

A: Official regulatory documents list a burning sensation at the application site as a 'Very Common' side effect, meaning it has been reported frequently in individuals using the product. This sensation is generally considered to be local to the area and reversible upon discontinuation of the cream.


Q: How does Canesten Ultra differ from other antifungal treatments that don't have 'Ultra'?

A: Canesten Ultra contains the active ingredient bifonazole, which is distinguished by a dual mechanism of action that interferes with the fungal organism's cell wall production in two ways. Official documentation notes its once-daily application, which is a distinguishing feature of its intended use pattern.


Q: What should I do if the area treated with Canesten Ultra looks worse?

A: Official information advises individuals to consult a doctor or pharmacist if the symptoms of the fungal infection do not improve after a defined period of treatment, such as seven days, or if the skin is blistered, broken, bleeding, or raw. Official guidance includes advice that consulting a healthcare professional is appropriate if local skin reactions become severe or persistent.


Q: Can using Canesten Ultra cause skin dryness or peeling?

A: The official safety profile for the cream includes several local skin reactions. Skin exfoliation (peeling) is listed as an adverse reaction. Dry skin is also listed in official safety documents as a potential local reaction.


Q: What are the official eligibility for using Canesten Ultra based on age restrictions in official documents?

A: The product is approved for use in adults, adolescents, and older children. However, regulatory documents specify that use in neonates and infants (under two years of age) is restricted and requires medical supervision for use.


Q: Can Canesten Ultra be used by people with specific long-term health conditions?

A: Official documentation requires caution and monitoring for individuals taking oral anticoagulants, such as warfarin, due to a potential interaction. No specific contraindications or mandatory dose adjustments are documented in the official labeling for patients with existing stable hepatic (liver) or renal (kidney) impairment.


Q: What if I accidentally swallow a small amount of Canesten Ultra?

A: Official documentation indicates that no acute intoxication risk is expected following the accidental oral ingestion of a topical dose. However, if the cream is swallowed accidentally, official guidance includes seeking medical attention immediately. Specialized medical procedures, such as gastric lavage, are usually performed only if clinical symptoms of overdose are apparent.


Q: How does the cream feel when applied to the skin (texture, absorption)?

A: The cream is intended to be applied as a thin layer and gently rubbed into the affected area. Regulatory information indicates that the active ingredient penetrates well into the infected skin layers. The official profile is defined by its minimal systemic absorption, meaning only small amounts of the drug enter the bloodstream.


Q: Does Canesten Ultra work on yeast infections, or just fungus?

A: The active substance, bifonazole, has a broad spectrum of activity that includes dermatophytes, molds, and yeasts, such as those that cause cutaneous candidiasis (a type of yeast infection). It is officially indicated for both fungal and yeast skin infections.


Q: What is the role of the inactive ingredients in Canesten Ultra?

A: The inactive ingredients (excipients), which include substances like cetostearyl alcohol and benzyl alcohol, form the cream base to aid in application, stability, and absorption into the skin layers. Official warnings note that some excipients may cause local skin reactions and may reduce the effectiveness of latex products.


Q: Are there any general expectations for recurrence after using Canesten Ultra?

A: Regulatory guidance emphasizes that the full duration of the specified treatment course must be completed, even if symptoms appear to have cleared. This adherence to the fixed course is the primary official measure described to ensure the infection has been fully addressed and to reduce the likelihood of recurrence.


Q: Is it true that you only need to use Canesten Ultra once?

A: The official use protocol specifies that Canesten Ultra (Bifonazole 1% cream) is applied once daily. The standard treatment requires continuous daily use for the full duration determined by the specific infection, and is not a single-dose therapy.


Q: What are the general expectations for improvement when using this drug?

A: The official guidance defines specific treatment durations, typically ranging from 2 to 4 weeks, during which the medicine should be used continuously. Patients are advised to consult a healthcare professional if the condition does not improve or appears to worsen after a defined period of treatment, such as one week.


Q: Can Canesten Ultra be used on skin that is broken or weeping?

A: The official use protocol requires the skin area to be washed and dried thoroughly before application. Regulatory documents advise that if the cream is applied to damaged or broken skin, particularly in individuals taking oral anticoagulants, closer monitoring by a healthcare professional may be required.


Q: Does the drug get absorbed into the bloodstream or just stay on the skin?

A: The active substance penetrates well into the infected layers of the skin where it is needed. However, the official profile for topical bifonazole is defined by its minimal systemic absorption through the skin, meaning only small amounts of the drug enter the bloodstream.


Q: What are the official recommendations about wearing socks or shoes after applying the cream?

A: Official regulatory documents specify that the preparation is not intended for use with occlusive bandages or dressings. Following application, the thin layer of cream is intended to be rubbed gently into the skin. Regulatory information indicates the importance of ensuring the treated area is dry and appropriately protected after application.


Q: Why is it described that this drug should only be used for a short period?

A: The instructions for use are tied to the standard treatment course required to clear the underlying fungal infection. The maximum duration for use is specified and fixed based on the type of infection, ranging from 2 to 4 weeks, and the use should not be extended beyond the officially recommended period.


Q: Why do official sources state to avoid covering the area with dressings?

A: Official documents explicitly state that the preparation is not intended for use with occlusive bandages or dressings. This instruction is particularly relevant for individuals taking oral anticoagulants, as occlusion and/or application to a large surface area may potentially increase systemic exposure, requiring closer medical monitoring.


Q: Can men and women use Canesten Ultra for the same conditions?

A: Official indications for use are defined by the type of fungal infection being treated (e.g., tinea, candidiasis) and not by the sex of the individual. The general dosing instructions are the same for all adults.

Advertisements

How should Canesten Ultra be stored and disposed of?

How to Store and Dispose of Canesten Ultra?

The storage and disposal of Canesten Ultra (Bifonazole Cream) are strictly defined by regulatory requirements to ensure product stability and environmental protection.


Official Storage Conditions

  • Temperature: The product must be stored at a temperature not exceeding 30°C.
  • Protection: Store in a cool dry place and ensure it is protected from direct sunlight.
  • Container: The cream must be kept in the original container/carton and manufacturer's tube, and should not be used after the expiry date.
  • Child Safety: All unused medicine must be kept out of the sight and reach of children.

Disposal Mandates

  • Procedure: Expired or unused medicine must not be disposed of via wastewater or household waste.
  • Action: Individuals are instructed to ask a pharmacist how to dispose of medicines no longer required, a measure specified to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Canesten Ultra found in:

A-Z Index: